Dr. Steven Tenn has significant experience evaluating antitrust and competition matters, specializing in merger investigations involving complex econometric analysis. He has analyzed competition matters across a range of industries including consumer products, health care, retail, and intermediate goods. His health care expertise includes pharmaceuticals, hospitals, physician practices, pharmacy benefit management, and medical equipment.
Prior to joining CRA, Dr. Tenn was an economist with the Federal Trade Commission (FTC) for 13 years, where he conducted economic and econometric analyses in high profile merger investigations and other antitrust matters. His work at the FTC involved designing and implementing empirical studies to test anticompetitive theories, evaluating efficiency claims, providing litigation support, and formulating settlements.
Dr. Tenn has conducted research on a variety of competition matters, most recently on the role of potential competition in the generic drug industry and the price effects of hospital mergers. His research has been published in academic journals that include Review of Economics and Statistics, International Journal of Industrial Organization, Journal of Health Economics, and Quantitative Marketing and Economics.
